NCT02463344View on ClinicalTrials.gov

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

CompletedOBSERVATIONAL
Enrollment

11

Participants

Timeline

Start Date

February 25, 2013

Primary Completion Date

August 19, 2019

Study Completion Date

August 19, 2019

Conditions
Age-Related Macular Degeneration
Interventions
BIOLOGICAL

MA09-hRPE

Cohort 1 50,000 cells Cohort 2 100,000 cells Cohort 2a Better Vision 100,000 cells Cohort 3 150,000 cells Cohort 4 200,000 cells

Trial Locations (4)

19107

Wills Eye Institute-Mid Atlantic Retina, Philadelphia

33136

Bascom Palmer Eye Institute, Miami

90095

Jules Stein Eye Institute, UCLA School of Medicine, Los Angeles

02114-3002

Mass Eye and Ear, Boston

All Listed Sponsors
lead

Astellas Institute for Regenerative Medicine

INDUSTRY

NCT02463344 - Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD | Biotech Hunter | Biotech Hunter